S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Synergy Pharmaceuticals Announces Positive Results of SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation|
|Progenics Receives $40 Million Milestone Following FDA Approval of RELISTOR for OIC Patients With Chronic Non-Cancer Pain|
|Progenics Pharmaceuticals Announces Third Quarter 2014 Financial Results|
|Sucampo Announces Third Quarter 2014 Financial Results|
|Clinical Data for AMITIZA(R) Lubiprostone to be Presented at the American College of Gastroenterology 2014 Annual Scientific Meeting|
|Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With Takeda|
|Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)|
|Theravance Biopharma, Inc. Reports Third Quarter 2014 Financial Results|
|Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada|
|MOVENTIG® Approved In The European Union For Opioid-Induced Constipation|
Click above to view more mutual fund data and stats for oic - Opus International Consultants Ltd.